The COVER study was an international observational cohort study aiming to assess how the COVID-19 coronavirus pandemic has changed the medical care of patients who have artery and vein problems. This project was a three-tiered study designed to fully elucidate the impact of the COVID-19 pandemic on vascular surgery across the world. The aim of Tier 1 was to document how the provision and availability of vascular services evolves over time per unit/region/country. The aim of Tier 2 was to prospectively capture data on all vascular procedures performed during the pandemic and understand the impact on outcomes in the short and medium-term (up to 1 year). The aim of Tier 3 was to document (prospectively) deviations from standards of care/practice during the pandemic in vascular patients.
The main objective of the COVER study was to understand and evaluate the impact of the COVID-19 pandemic on global vascular practice and the effect on outcomes for patients presenting/receiving treatment during the pandemic.
Population
All patients with a vascular pathology.
Outcomes of interest
Tier 1: state of vascular services per centre weekly.
Tier 2: procedures performed in each centre.
Tier 3: assessment of longer-term outcomes.
The study is formally supported by the Vascular Society of Great Britain and Ireland (VSGBI), the British Society for Endovascular Therapy (BSET), the Rouleaux Club, the NIHR, SingVasc and several national vascular surgery societies in Europe, Asia, Australia, New Zealand, and the Americas.
Publications: